Last Updated: August 2, 2026

SODIUM CHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Chloride, and what generic alternatives are available?

Sodium Chloride is a drug marketed by Abbott, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Miles, Otsuka Icu Medcl, Medefil Inc, Hikma, Nexus, Spectra Mdcl Devices, Fresenius Medcl, Gvs Tm, Laboratorios Grifols, Liebel-flarsheim, Icu Medical Inc, Jubilant Cadista, Nephron, Taro, and Abraxis Pharm. and is included in fifty-four NDAs.

The generic ingredient in SODIUM CHLORIDE is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM CHLORIDE?
  • What are the global sales for SODIUM CHLORIDE?
  • What is Average Wholesale Price for SODIUM CHLORIDE?
Summary for SODIUM CHLORIDE
US Patents:0
Applicants:20
NDAs:54
Raw Ingredient (Bulk) Api Vendors: 1
Patent Applications: 3,482
Drug Prices: Drug price information for SODIUM CHLORIDE
What excipients (inactive ingredients) are in SODIUM CHLORIDE?SODIUM CHLORIDE excipients list
DailyMed Link:SODIUM CHLORIDE at DailyMed

US Patents and Regulatory Information for SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;INJECTION 077407-002 Aug 11, 2006 AP RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Liebel-flarsheim SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 021569-001 Jul 27, 2006 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 018722-004 Nov 9, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa SODIUM CHLORIDE 23.4% sodium chloride INJECTABLE;INJECTION 217796-001 Jul 11, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.